| Literature DB >> 19134539 |
Mark Freilich1, Dion Stub, Donald Esmore, Justin Negri, Robert Salamonsen, Peter Bergin, Angeline Leet, Meroula Richardson, Andrew Taylor, John Woodard, David Kaye, Franklin Rosenfeldt.
Abstract
We report the clinical course of a 16-year-old girl in remission from non-Hodgkin's lymphoma who presented in cardiogenic shock due to a severe anthracycline cardiomyopathy. The patient was initially stabilized using central extracorporeal membrane oxygenation support, followed by conversion to a left ventricular assist device. Unexpected evidence of cardiac recovery 9 months after implant enabled device weaning during a 3-month period, culminating in successful device explantation 1 year after implant. The patient survives 18 months after explant in New York Heart Association class I, on conventional heart failure medical management and metabolic therapy.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19134539 DOI： 10.1016/j.healun.2008.10.002
Source DB: PubMed Journal: J Heart Lung Transplant ISSN： 1053-2498 Impact factor: 10.247